orks fast and offers flexible insulin dosing to help manage mealtime blood sugar levels. It should be administered within 15 minutes before or within 20 minutes after the start of a meal. Along with exercise, a basal insulin, and a proper meal plan, Apidra(R) is proven to help reduce A1C levels in adults and children (4 years and older) with type 1 diabetes and adults with type 2 diabetes. Apidra(R) can be administered using an insulin pump, vial and syringe, the OptiClik(R) reusable insulin delivery device, the Apidra(R) SoloSTAR(R) prefilled disposable insulin pen or intravenously under proper medical supervision in a clinical setting.
Apidra(R) SoloSTAR(R) is a prefilled, disposable insulin pen that is easy-to-use. Apidra(R) SoloSTAR(R) eliminates the need for the patient to change cartridges.
Apidra(R) SoloSTAR(R) should be kept in cool storage (36 degrees F - 46 degrees F [2 degrees C - 8 degrees C]) until first use. Once in use, it can be kept at room temperature, as long as it remains below 77 degrees F [25 degrees C], away from direct heat and light, and can be used for up to 28 days.
Apidra(R) is from the maker of Lantus(R), the number one prescribed insulin.*
About Lantus(R) and Lantus(R) SoloSTAR(R)
Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. Insulins have a "peak of action," which refers to the time at which insulin reaches its maximum effect in the body. With Lantus(R), the insulin is released into the bloodstream at a relatively constant rate throughout the day and night; therefore it has no pronounced peak.
Lantus(R) SoloSTAR(R) is easy-to-use and requires a few straightforward steps to use it properly. Lantus(R) SoloSTAR(R) eliminates the need for the patient to change cartridges.
Lantus(R) SoloSTAR(R) should be kept in cool storage (36 degrees F - 46 degrees F [2 degrees C - 8 degrePage: 1 2 3 4 5 6 7 Related biology technology :1
. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait2
. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania3
. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox4
. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program5
. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia6
. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)7
. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir8
. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections9
. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer10
. FDA Approves Genzymes Renvela(TM) for Dialysis Patients11
. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML